Microvascular Therapeutics
Business Services · Arizona, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1635 E 18th St, Tucson, Arizona, 85719, ...Phone Number
(520) 624-6688Website
www.mvtpharma.comRevenue
<$5 MillionIndustry
About Microvascular Therapeutics
MVT Pharma is a biotechnology company that specializes in the development of microbubble and nanotechnology products aimed at enhancing the diagnosis and treatment of various diseases. They have pioneered ultrasound contrast agents and theranostics, with their flagship product, MVT-100, having completed Phase II clinical trials for echocardiography. The company is focused on innovative solutions for conditions such as brain cancer, myocardial microvascular obstruction, Alzheimer's disease, and breast cancer, utilizing advanced ultrasound technologies. MVT Pharma's intended clients include healthcare providers and institutions involved in diagnostic imaging and therapeutic interventions.Explore more
Microvascular Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Microvascular Therapeutics
Compare insights from companies similar to Microvascular Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2014
MK
Michael KirbergerSenior Science Writer and Editor, SME, Patent Portfolio Manager
Microvascular Therapeutics Tech Stack
A closer look at the technologies used by Microvascular Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Microvascular Therapeutics
Sign Up For FreeTo access detailed company insights
MVT Pharma is a biotechnology company that specializes in the development of microbubble and nanotechnology products aimed at enhancing the diagnosis and treatment of various diseases. They have pioneered ultrasound contrast agents and theranostics, with their flagship product, MVT-100, having completed Phase II clinical trials for echocardiography... Read More
